| Tretinoin | Approved Investigational Nutraceutical | ERGIC3 | 51614 |
upregulated | Tretinoin results in increased expression of ERGIC3 mRNA | 20q11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | ERICH3 | 127254 |
downregulated | Tretinoin results in decreased expression of ERICH3 mRNA | 1p31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ERMP1 | 79956 |
upregulated | Tretinoin results in increased expression of ERMP1 mRNA | 9p24.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ERN1 | 2081 |
upregulated | Tretinoin results in increased expression of ERN1 mRNA | 17q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ERO1B | 56605 |
upregulated | Tretinoin results in increased expression of ERO1B mRNA | 1q42.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ERP27 | 121506 |
upregulated | Tretinoin results in increased expression of ERP27 mRNA | 12p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ERRFI1 | 54206 |
upregulated | Tretinoin results in increased expression of ERRFI1 mRNA | 1p36.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ESRG | 790952 |
downregulated | Tretinoin results in decreased expression of ESRG mRNA | 3p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ESRP1 | 54845 |
upregulated | Tretinoin results in increased expression of ESRP1 mRNA | 8q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ESRP2 | 80004 |
upregulated | Tretinoin results in increased expression of ESRP2 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ESRRG | 2104 |
upregulated | Tretinoin results in increased expression of ESRRG mRNA | 1q41 | |
| Tretinoin | Approved Investigational Nutraceutical | ETFDH | 2110 |
upregulated | Tretinoin results in increased expression of ETFDH mRNA | 4q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ETV3 | 2117 |
upregulated | Tretinoin results in increased expression of ETV3 mRNA | 1q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ETV5 | 2119 |
downregulated | Tretinoin results in decreased expression of ETV5 mRNA | 3q27.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EVA1A | 84141 |
upregulated | Tretinoin results in increased expression of EVA1A mRNA | 2p12 | |
| Tretinoin | Approved Investigational Nutraceutical | EVC | 2121 |
upregulated | Tretinoin results in increased expression of EVC mRNA | 4p16.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EVI2B | 2124 |
upregulated | Tretinoin results in increased expression of EVI2B mRNA | 17q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EVX1 | 2128 |
downregulated | Tretinoin results in decreased expression of EVX1 mRNA | 7p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EXOC3 | 11336 |
upregulated | Tretinoin results in increased expression of EXOC3 mRNA | 5p15.33 | |
| Tretinoin | Approved Investigational Nutraceutical | EXOSC2 | 23404 |
downregulated | Tretinoin results in decreased expression of EXOSC2 mRNA | 9q34.12 | |
| Tretinoin | Approved Investigational Nutraceutical | EXOSC3 | 51010 |
downregulated | Tretinoin results in decreased expression of EXOSC3 mRNA | 9p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EXOSC5 | 56915 |
downregulated | Tretinoin results in decreased expression of EXOSC5 mRNA | 19q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | EXOSC7 | 23016 |
downregulated | Tretinoin results in decreased expression of EXOSC7 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | EXPH5 | 23086 |
upregulated | Tretinoin results in increased expression of EXPH5 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | EXTL2 | 2135 |
upregulated | Tretinoin results in increased expression of EXTL2 mRNA | 1p21.2 | |